Social media boosting patient recruitment, but FDA guidance needed

By Gareth Macdonald

- Last updated on GMT

Related tags: Contract research organisations, Food and drug administration, Contract research organization

CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed. spoke with Brian Loew, CEO of Inspire, an online community of over 70 disease-specific patient communities, who explained that the benefits go beyond access to patients.

“It’s not just access to large number of patients, it’s the fact that those patients are deciding in large number to participate in clinical trials.”

Loew went on to explain that this volunteering process helps contract research organisations and pharmas tackle some of the prescreening, selection and permission hurdles that can otherwise hamper recruitment.

However, he added, CROs still face regulatory hurdles when accessing these types of social networks that would benefit from further clarification from regulators.

The FDA could help us all by being clear about what is ok and what is not ok…and the absence of that clarity is making it difficult for industry​.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more